These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31724242)

  • 21. Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease.
    Jay TR; Hirsch AM; Broihier ML; Miller CM; Neilson LE; Ransohoff RM; Lamb BT; Landreth GE
    J Neurosci; 2017 Jan; 37(3):637-647. PubMed ID: 28100745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer's disease.
    Claes C; Danhash EP; Hasselmann J; Chadarevian JP; Shabestari SK; England WE; Lim TE; Hidalgo JLS; Spitale RC; Davtyan H; Blurton-Jones M
    Mol Neurodegener; 2021 Jul; 16(1):50. PubMed ID: 34301296
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Durmanova V; Javor J; Parnicka Z; Minarik G; Ocenasova A; Vaseckova B; Kiralyova I; Sutovsky S; Petrovic R; Shawkatova I
    J Integr Neurosci; 2022 Jun; 21(4):105. PubMed ID: 35864757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer risk-increasing TREM2 variant causes aberrant cortical synapse density and promotes network hyperexcitability in mouse models.
    Das M; Mao W; Voskobiynyk Y; Necula D; Lew I; Petersen C; Zahn A; Yu GQ; Yu X; Smith N; Sayed FA; Gan L; Paz JT; Mucke L
    Neurobiol Dis; 2023 Oct; 186():106263. PubMed ID: 37591465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rare coding variant in TREM2 increases risk for Alzheimer's disease in Han Chinese.
    Jiang T; Tan L; Chen Q; Tan MS; Zhou JS; Zhu XC; Lu H; Wang HF; Zhang YD; Yu JT
    Neurobiol Aging; 2016 Jun; 42():217.e1-3. PubMed ID: 27067662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis.
    Cady J; Koval ED; Benitez BA; Zaidman C; Jockel-Balsarotti J; Allred P; Baloh RH; Ravits J; Simpson E; Appel SH; Pestronk A; Goate AM; Miller TM; Cruchaga C; Harms MB
    JAMA Neurol; 2014 Apr; 71(4):449-53. PubMed ID: 24535663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation.
    Zheng H; Liu CC; Atagi Y; Chen XF; Jia L; Yang L; He W; Zhang X; Kang SS; Rosenberry TL; Fryer JD; Zhang YW; Xu H; Bu G
    Neurobiol Aging; 2016 Jun; 42():132-41. PubMed ID: 27143430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frontobasal gray matter loss is associated with the TREM2 p.R47H variant.
    Luis EO; Ortega-Cubero S; Lamet I; Razquin C; Cruchaga C; Benitez BA; Lorenzo E; Irigoyen J; ; Pastor MA; Pastor P
    Neurobiol Aging; 2014 Dec; 35(12):2681-2690. PubMed ID: 25027412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TREM2 R47H variant and risk of essential tremor: a cross-sectional international multicenter study.
    Ortega-Cubero S; Lorenzo-Betancor O; Lorenzo E; Agúndez JA; Jiménez-Jiménez FJ; Ross OA; Wurster I; Mielke C; Lin JJ; Coria F; Clarimon J; Ezquerra M; Brighina L; Annesi G; Alonso-Navarro H; García-Martin E; Gironell A; Marti MJ; Yueh KC; Wszolek ZK; Sharma M; Berg D; Krüger R; Pastor MA; Pastor P
    Parkinsonism Relat Disord; 2015 Mar; 21(3):306-9. PubMed ID: 25585992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-Like Receptor 4 Plays a Significant Role in the Biochemical and Neurological Alterations Observed in Two Distinct Mice Models of Huntington's Disease.
    Martínez-Gopar PE; Pérez-Rodríguez MJ; Angeles-López QD; Tristán-López L; González-Espinosa C; Pérez-Severiano F
    Mol Neurobiol; 2023 May; 60(5):2678-2690. PubMed ID: 36701109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease-associated R47H TREM2 increases, but wild-type TREM2 decreases, microglial phagocytosis of synaptosomes and neuronal loss.
    Popescu AS; Butler CA; Allendorf DH; Piers TM; Mallach A; Roewe J; Reinhardt P; Cinti A; Redaelli L; Boudesco C; Pradier L; Pocock JM; Thornton P; Brown GC
    Glia; 2023 Apr; 71(4):974-990. PubMed ID: 36480007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease.
    Rayaprolu S; Mullen B; Baker M; Lynch T; Finger E; Seeley WW; Hatanpaa KJ; Lomen-Hoerth C; Kertesz A; Bigio EH; Lippa C; Josephs KA; Knopman DS; White CL; Caselli R; Mackenzie IR; Miller BL; Boczarska-Jedynak M; Opala G; Krygowska-Wajs A; Barcikowska M; Younkin SG; Petersen RC; Ertekin-Taner N; Uitti RJ; Meschia JF; Boylan KB; Boeve BF; Graff-Radford NR; Wszolek ZK; Dickson DW; Rademakers R; Ross OA
    Mol Neurodegener; 2013 Jun; 8():19. PubMed ID: 23800361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.
    Pottier C; Wallon D; Rousseau S; Rovelet-Lecrux A; Richard AC; Rollin-Sillaire A; Frebourg T; Campion D; Hannequin D
    J Alzheimers Dis; 2013; 35(1):45-9. PubMed ID: 23380991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trem2 Splicing and Expression are Preserved in a Human Aβ-producing, Rat Knock-in Model of Trem2-R47H Alzheimer's Risk Variant.
    Tambini MD; D'Adamio L
    Sci Rep; 2020 Mar; 10(1):4122. PubMed ID: 32139718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TREM2 Variants and Neurodegenerative Diseases: A Systematic Review and Meta-Analysis.
    Zhou SL; Tan CC; Hou XH; Cao XP; Tan L; Yu JT
    J Alzheimers Dis; 2019; 68(3):1171-1184. PubMed ID: 30883352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism.
    Song WM; Joshita S; Zhou Y; Ulland TK; Gilfillan S; Colonna M
    J Exp Med; 2018 Mar; 215(3):745-760. PubMed ID: 29321225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A reporter cell system for the triggering receptor expressed on myeloid cells 2 reveals differential effects of disease-associated variants on receptor signaling and activation by antibodies against the stalk region.
    Ibach M; Mathews M; Linnartz-Gerlach B; Theil S; Kumar S; Feederle R; Brüstle O; Neumann H; Walter J
    Glia; 2021 May; 69(5):1126-1139. PubMed ID: 33314333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variant of TREM2 associated with the risk of Alzheimer's disease.
    Jonsson T; Stefansson H; Steinberg S; Jonsdottir I; Jonsson PV; Snaedal J; Bjornsson S; Huttenlocher J; Levey AI; Lah JJ; Rujescu D; Hampel H; Giegling I; Andreassen OA; Engedal K; Ulstein I; Djurovic S; Ibrahim-Verbaas C; Hofman A; Ikram MA; van Duijn CM; Thorsteinsdottir U; Kong A; Stefansson K
    N Engl J Med; 2013 Jan; 368(2):107-16. PubMed ID: 23150908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TREM2 variants: new keys to decipher Alzheimer disease pathogenesis.
    Colonna M; Wang Y
    Nat Rev Neurosci; 2016 Apr; 17(4):201-7. PubMed ID: 26911435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triggering receptor expressed on myeloid cells 2 variant is rare in late-onset Alzheimer's disease in Han Chinese individuals.
    Yu JT; Jiang T; Wang YL; Wang HF; Zhang W; Hu N; Tan L; Sun L; Tan MS; Zhu XC; Tan L
    Neurobiol Aging; 2014 Apr; 35(4):937.e1-3. PubMed ID: 24184202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.